|
|
|
Cancer Therapeutics |
| |
Murex Pharmaceuticals
Licenses Ariadne’s Pathway Studio Software Solution To Be
Utilized For Cancer Therapeutics Development
Other Topics: Orthopedic
Templating Solution, Patient
Care Informatics, Portable
Patient Medical Records
PRWEB
July 27, 2006
Ariadne Genomics, Inc. today announced that Murex
Pharmaceuticals (Dallas, Texas) has licensed its Pathway Studio®
software solution for the visualization and analysis of
biological pathways and gene regulation networks. Murex will use
Pathway Studio to develop computer-based models for the
identification and validation of cancer targets.
Rockville, MD -- Ariadne Genomics, Inc. today announced
that Murex Pharmaceuticals (Dallas, Texas) has licensed its
Pathway Studio® software solution for the visualization and
analysis of biological pathways and gene regulation networks.
Murex will use Pathway Studio to develop computer-based models
for the identification and validation of cancer targets. |
| |
|
|
| |
Pathway Studio
(formerly known as PathwayAssist) enables life scientists to
identify relationships among proteins, small molecules, cell
processes and treatments, and automatically extract relevant
biological interactions from scientific literature. With the
product’s resident ResNet database of over 1,000,000
interactions extracted from PubMed and approximately 1000
predefined pathways, researchers can easily reconstruct
regulatory networks from their microarray and proteomics data,
identify biomarkers, and model drug responses.
“It’s hard to overestimate the importance of Pathway Studio in
our development of cancer therapies based on patients’
individual gene expression data,” commented David Shanahan,
President and CEO of Murex Pharmaceuticals. “Pathway Studio will
accelerate our development efforts as well as help to further
increase the safety of our products”.
“Pathway Studio is a must-have tool for cancer target research,”
added Ilya Mazo, President of Ariadne. “The software keeps the
on-board ResNet database up-to-date, automatically extracting
relevant biological interactions from literature, while the
flexible user interface allows database queries to expand known
pathways and build regulatory networks focused on specific
research tasks, such as drug target or biomarker discovery.”
Pathway Studio is available as a desktop or workgroup solution.
A 20 day fully functional trial version can be found on the
Ariadne website at www.ariadnegenomics.com.
About Murex Pharmaceuticals
Murex Pharmaceuticals is a privately held biotechnology company
dedicated to developing cancer therapies based on an
individual’s tumor biology. The company is headquartered in
Dallas, Texas, with research and development efforts underway at
labs in Boston, Massachusetts, Carrollton, Texas, and San
Francisco, California.
About Ariadne
Ariadne develops systems biology software for life science
research. Products include Pathway Studio® (formerly
PathwayAssist) leading pathway analysis software and
PathwayExpert™ informatics platform for the research of cellular
regulation and drug response modeling. Ariadne software is
equipped with MedScan™, a mature information extraction
technology based on domain-specific natural language processing
(NLP), and comes with a ResNet family of molecular network
databases, both automatically generated and manually curated.
MedScan Reader™ is a biomedical literature browser that greatly
facilitates the reading of scientific text by automatically
extracting and displaying the information of interest. |
| |
|
|
| |
|
|
